A 2022 systematic review of clinical trials has shown that in patients with metabolic disorders, IF can help reduce insulin resistance, improve glucose and lipid metabolism, and reduce body weight, thus being an effective therapeutic option in these patients (86)
However, it may also be associated with the gastrointestinal side effects commonly observed with GLP-1 receptor agonists, such as nausea, vomiting, and diarrhea
They are not a shortcut, and they do not eliminate the need for lifestyle changes
This insight helps your provider forecast whether you'll need standard or higher doses and how long suppression will feel pronounced each week, enabling faster personalization of your therapy
Keep Expectations Realistic Some people have overly demanding expectations and expect far more of themselves than is reasonable